Efficacy of Rehabilitation in Multiple Sclerosis

Abstract

References

Abrams MW A comprehensive physical therapy program for the treatment of multiple sclerosis patients. Physical Therapy 1968;48: 337-41.

Aisen ML , Holzer M. , Rosen M. , Dietz M. , McDowell F.

Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury. Archives of

Neurology 1991;48(5):513-15.

Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. The Practitioner 1964;192:540-42.

Basmajian JV Lioresal (baclofen) treatment of spasticity in multiple sclerosis: further experience with double-blind cross-over. American Journal of Physical Medicine 1975;54:175-77.

Basmajian JV , Shankardass K. , Russell D. Ketazolam once daily for spasticity: double-blind cross-over study . Archives of Physical Medicine and Rehabilitation 1986;67(8):556-57.

Beukelman DR , Kraft GH , Freal J. Expressive communication disorders in persons with multiple sclerosis: a survey . Archives of Physical Medicine and Rehabilitation 1985;66(10):675-77.

Blaivas JG (1980). Management of bladder dysfunction in multiple sclerosis. Neurology 1980;30(7):12-18.

Blaivas JG , Holland NJ , Giesser B. , LaRocca NG , Madonna M. , Scheinberg L. Multiple sclerosis bladder: studies and care. Annals New York Academy of Sciences 1984;436:328-46.

Block JM , Kester NC Role of rehabilitation in the management of multiple sclerosis. Modem Treatment 1970;7(5):930-40.

10.

Brar SP , Smith MB , Nelson LM , Franklin GM , Cobble ND Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1991;72:186-89.

11.

Cailliet R. Rehabilitation in multiple sclerosis. In S. Licht (Ed.). Rehabilitation and Medicine. Baltimore: Waverly Press, 1968:446-59.

12.

Carey RG , Seibert JH , Posavac EJ Who makes the most progress in inpatient rehabilitation? An analysis of functional gain. Archives of Physical Medicine and Rehabilitation 1988;69:337-43.

13.

Crawford JD , Mclvor GP Group psychotherapy: benefit in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1985;66:810-13.

14.

Crawford JD , Mclvor GP Stress management for multiple sclerosis patients. Psychological Reports 1987;61:423-29.

15.

Darley FL , Brown JR , Golstein NP Dysarthria in multiple sclerosis. Journal of Speech and Hearing Research 1972;15:229-45.

16.

Day M. , Day E. , Herman R. Group therapy in patients with multiple sclerosis. Archives of Neurology and Psychiatry 1953;69:193-201.

17.

DeLisa JA , Miller RM , Mikulic M. , Hammond MC Multiple sclerosis: Part II. Common functional problems and rehabilitation . American Family Physician 1985a;32(5):127-32.

18.

DeLisa JA , Hammond MC , Mikulic M. , Miller RM Multiple sclerosis: Part I. Common physical disabilities and rehabilitation . American Family Physician 1985b;32(4):157-63.

19.

Erickson RP , Lie MR , Wineinger MA Rehabilitation in multiple sclerosis. Mayo Clinic Proceedings 1989;64:818-28.

20.

Farmakides MN , Boone DR Speech problems of patients with multiple sclerosis. Journal of Speech and Hearing Disorders 1960;25:385-90.

21.

Feigenson JS , Scheinberg L. , Catalano M. , Polkow L. , Mantegazza PM , Feigenson WD , LaRocca NG. The cost-effectiveness of multiple sclerosis rehabilitation: a model. Neurology 1981;31(10):1316-22.

22.

Feldman RG , Kelly-Hayes M. , Conomy JP , Foley JM Baclofen for spasticity in multiple sclerosis: A double-blind crossover and three-year study. Neurology 1978;28:1094-98.

23.

Foley FW , Bedell JR , LaRocca NG , Scheinberg LC , Reznikoff M. Efficacy of stress-inoculation training in coping with multiple sclerosis . Journal of Consulting and Clinical Psychology 1987;55:919-22.

24.

Francabandera FL , Holland NJ , Wiesel-Levison P. , Scheinberg LC

Multiple sclerosis rehabilitation: inpatient vs. outpatient. Rehabilitation

Nursing 1988;13(5):251-53.

25.

Frankel D. Multiple sclerosis. In D. Umphred (Ed.). Neurological Rehabilitation. St. Louis: C.V. Mosby Company, 1985:398-415.

26.

Gehlsen G. , Beekman K. , Assmann N. , Winant D. , Seidle M. , Carter A. (1986). Gait characteristics in multiple sclerosis: progressive changes and effects of exercise on parameters. Archives of Physical Medicine and Rehabilitation 1986;67:536-39.

27.

Geronemus DF , Holland NJ , Sprinzeles LL , Scheinberg LC Chronic ambulatory care: A model. American Rehabilitation September-October 1980, 25-29.

28.

Goldstein I. , Siroky MB , Sax DS , Krane RJ The urodynamic characteristics of multiple sclerosis. Journal of Urology 1982; 128:541.

29.

Granger CV (1981). Assessment of functional status: a model for multiple sclerosis. Acta Neurologica Scandinavica 1981 ;64:40-47.

30.

Graves WH Keynote address, NIDRR Medical Sciences Project Directors' Meeting , Chantilly Virginia, October 24, 1991 (unpublished).

31.

Greenspun B. , Stineman M. , Agri R. Multiple sclerosis and rehabilitation outcome. Archives of Physical Medicine and Rehabilitation 1987;68:434-37.

32.

Haber A. , LaRocca NG Minimal record of disability for multiple sclerosis. New York: National Multiple Sclerosis Society, 1985.

33.

Hartings M. , Pavlov M. , Davis F. Group counseling of multiple sclerosis patients in a program of comprehensive care. Journal of Chronic Diseases 1976;29:65-73.

34.

Kurtzke JF Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.

35.

Lapierre Y. , Bouchard S. , Tansey C. , Gendron D. , Barkas WJ , Francis GS

Treatment of spasticity with tizanidine in multiple sclerosis. Canadian

Journal of Neurological Sciences 1987 ;14(Supplement):513-17.

36.

Larcombe NA , Wilson PH An evaluation of cognitive behavior therapy for depression in patients with multiple sclerosis. British Journal of Rehabilitation Research 1984;145, 366-71.

37.

LaRocca NO , Dince W. , Caruso LS , Foley FW , Kalb RC , Masur DM , Smith CR Cognitive retraining in multiple sclerosis. Presentation at Neurobehavioral Disorders in Multiple Sclerosis: Diagnosis, Underlying Pathology, Natural History and Therapeutic Intervention . Bergamo, Italy, June 26, 1992 (unpublished).

38.

Leo GJ , Rao SM Effects of intravenous physostigmine and lecithin on memory loss in multiple sclerosis: report of a pilot study. Journal of Neurologic Rehabilitation 1988;2:123-29.

39.

Maloney FP , Burks JS , Ringel SP Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders . Philadelphia: J.B. Lippincott Co., 1985.

40.

National Center for Health Statistics, Collins, J.G. Prevalence of selected chronic conditions, United States, 1983-85. Advance data from vital and health statistics. No. 155. DHHS Pub. No. (PHS) 88-1250. Hyattsville, MD: Public Health Service, 1988.

41.

Parke B. , Penn RD , Savoy SM , Corcos D. Functional outcome after delivery of intrathecal baclofen. Archives of Physical Medicine and Rehabilitation 1989;70(1):30-32.

42.

Piazza DH , Diokno AC Review of neurogenic bladder in multiple sclerosis. Urology 1979;14:33-35.

43.

Prigatano GP , Fordyce D. , Zeiner HK , Roueche JR , Pepping M. , Wood BC Neuropsychological rehabilitation after brain injury. Baltimore: Johns Hopkins University Press, 1986.

44.

Reding MJ , LaRocca NG , Madonna M. Acute-hospital care versus rehabilitation hospitalization for management of nonemergent complications in multiple sclerosis. Journal of Neurologic Rehabilitation 1987;1(1):13-17.

45.

Rusk HA Rehabilitation medicine. St. Louis: C.V. Mosby Company, 1971.

46.

Sawa GM , Paty DW The use of baclofen in treatment of spasticity in multiple sclerosis. Canadian Journal of Neurological Sciences 1979;6:351-54.

47.

Scheinberg L. , Smith CR Rehabilitation of patients with multiple sclerosis. Neurologic Clinics 1987;5(4):585-600.

48.

Schneitzer L. Rehabilitation of patients with multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1978;59:430-37.

49.

Schoenberg HW , Gutrich JM Management of vesicle dysfunction in multiple sclerosis. Urology 1980;16:444-47.

50.

Smith CR , Scheinberg LC Symptomatic treatment and rehabilitation in multiple sclerosis. In S.D. Cook (Ed.). Handbook of multiple sclerosis . New York: Marcel Dekker, 1990:327-49.

51.

Smith CR , LaRocca NG , Giesser BS , Scheinberg LC High-dose oral baclofen: experience in patients with multiple sclerosis . Neurology 1991:41:1829-31.

52.

Snow BJ , Tsui Jkc , Bhatt MH , Varelas M. , Hashimoto SA , Calne DB Treatment of spasticity with botulinum toxin: a double-blind study . Annals of Neurology 1990;28(4):512-15.

53.

Sullivan Mjl , Dehoux E. , Buchanan DC An approach to cognitive rehabilitation in multiple sclerosis. Canadian Journal of Rehabilitation 1989;3:77-85.

54.

Tolonen U. , Myllyla V. , Hokkanen E. ( 1979). Treatment of spasticity with baclofen and salbutamol . Current Therapeutic Research 1979;25: 251-59.

55.

World Health Organization. International classification of impairments, disabilities and handicaps. Geneva, Switzerland, 1980.

56.

Zierski J. , Muller H. , Dralle D. , Wurdinger T. Implanted pump systems for treatment of spasticity. Acta Neurochirurgica 1988;43:94-99.